AI will have a vast impact on the world. Anthropic is a public benefit corporation dedicated to securing its benefits and mitigating its risks.
Roadshow underway · Pricing expected November 18 · Trading begins November 19 under ticker ANT on Nasdaq
Nasdaq Global Select Market
Final price set November 18 (EST)
Class A common stock
Nov 10: Roadshow started
Nov 18: Pricing
Nov 19: First trade
Request allocation of Class A shares at the IPO offering price.
>12x YoY growth
>12x YoY growth
Since Q1’25
Operating margin (3%)
Key chapters from the roadshow:
The IPO process begins with a roadshow starting on November 10th (EST). Subject to regulatory clearance, the final IPO share price is expected to be set on November 18th (EST), and shares are expected to begin publicly trading on November 19th (EST).
Anthropic is offering shares of its Class A common stock to the public, which will trade on Nasdaq under the ticker symbol “ANT”.
You can request shares through a participating brokerage platform. To participate, you must have an active account and submit an indication of interest through their platform.
Your brokerage account or investing app will confirm whether you’re eligible when you submit your request to participate.
The final IPO price is expected to be determined on November 18th (EST), based on regulatory clearance, investor demand and market conditions.
Your brokerage account or investing app will confirm your allocation on the first day of trading, which is expected to be November 19th (EST).
Shares bought in the IPO will be purchased at the offering price, which is expected to be set on November 18th (EST). Shares bought after Anthropic starts trading will be purchased at the prevailing market price at that time.
There is no guarantee that any investor will receive all or any of the shares they apply for in the Anthropic IPO. However, you should be ready to purchase all the shares for which you apply.
A prospectus is a regulatory filing that provides detailed information about Anthropic’s business, financial statements, risk factors, management team, use of proceeds, offering details, among other items. Investors should review the prospectus closely before investing.